Abstract

Early-life exposure to environmental toxins like tobacco can permanently re-program body structure and function. Here, we investigated the long-term effects on mouse adult sleep phenotype exerted by early-life exposure to nicotine or to its principal metabolite, cotinine. Moreover, we investigated whether these effects occurred together with a reprogramming of the activity of the hippocampus, a key structure to coordinate the hormonal stress response. Adult male mice born from dams subjected to nicotine (NIC), cotinine (COT) or vehicle (CTRL) treatment in drinking water were implanted with electrodes for sleep recordings. NIC and COT mice spent significantly more time awake than CTRL mice at the transition between the rest (light) and the activity (dark) period. NIC and COT mice showed hippocampal glucocorticoid receptor (GR) downregulation compared to CTRL mice, and NIC mice also showed hippocampal mineralocorticoid receptor downregulation. Hippocampal GR expression significantly and inversely correlated with the amount of wakefulness at the light-to-dark transition, while no changes in DNA methylation were found. We demonstrated that early-life exposure to nicotine (and cotinine) concomitantly entails long-lasting reprogramming of hippocampal activity and sleep phenotype suggesting that the adult sleep phenotype may be modulated by events that occurred during that critical period of life.

Details

Title
Early-life nicotine or cotinine exposure produces long-lasting sleep alterations and downregulation of hippocampal corticosteroid receptors in adult mice
Author
Bastianini Stefano 1 ; Lo, Martire Viviana 1 ; Alvente Sara 1 ; Berteotti Chiara 1 ; Matteoli Gabriele 1 ; Rullo, Laura 2 ; Stamatakos Serena 2 ; Silvani Alessandro 1 ; Candeletti Sanzio 2 ; Romualdi Patrizia 2 ; Cohen, Gary 3 ; Zoccoli Giovanna 1 

 University of Bologna, PRISM Lab, Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum, Bologna, Italy (GRID:grid.6292.f) (ISNI:0000 0004 1757 1758) 
 University of Bologna, Department of Pharmacy and Biotechnology, Alma Mater Studiorum, Bologna, Italy (GRID:grid.6292.f) (ISNI:0000 0004 1757 1758) 
 Karolinska Institutet, Department of Women and Child Health, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Royal North Shore Hospital, Centre for Sleep Health and Research, Sleep Investigation Laboratory, Sydney, Australia (GRID:grid.412703.3) (ISNI:0000 0004 0587 9093) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2609525645
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.